Marvell Technology, Inc. (MRVL) valuation

SEC pipeline catching up: most recent reported quarter (2026-04-30) isn't incorporated yet — this page is anchored to 2026-01-31 (FY 2026 · 10-K). New filings land within a few weekday pipeline runs.

Share price $78.92 · As of last filing 2026-01-31

Price-to-Earnings

P/E · Trailing Diluted
25.62×
P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing
49.57×
P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing
2.02%
FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing
28.81×
EV/EBITDA history →

Price-to-Sales

P/S · Trailing
8.42×
P/S history →

Price-to-Book

P/B · Latest filing
4.82×
P/B history →

Earning Power Value & reverse-DCF

Not investment advice. Both models below are mechanical algorithms — they don't account for any business-, industry-, or situation-specific context (management changes, regulatory shifts, segment mix, accounting one-offs beyond what XBRL tagging captures, etc.). Neither number is a forecast, a price target, or a suggestion to buy or sell any stock. They are starting points for further analysis, not conclusions.
A note on share counts — three different denominators in play
XBRL exposes three different share figures, and each is the right denominator for a different question:
  • Weighted-average diluted — the filed P/E denominator (NetIncome ÷ this = diluted EPS). Used on the P/E card above because EPS is pulled directly from the EarningsPerShareDiluted XBRL tag and is locked to that share count.
  • Point-in-time CSO (latest CommonStockSharesOutstanding) — matches a point-in-time price for market-cap-based multiples (P/S, P/B, EV/EBITDA, P/FCF, FCF Yield) and the WACC equity weight. Cards labelled "shares outstanding" use this.
  • TSM-scaled diluted — point-in-time CSO scaled by the latest filer-disclosed (WeightedAverageDiluted ÷ WeightedAverageBasic) ratio. Estimates today's fully-diluted share count and is the denominator for the EPV per share and the reverse-DCF equity bridge below.
The three counts drift apart for high-buyback filers; the methodology diluted-shares note walks through which one fits which context and why.

Earning Power Value

Bruce Greenwald's no-growth fair-value floor: capitalise after-tax operating earnings (NOPAT) at the cost of capital (WACC), then bridge to equity (+ excess cash, − total debt, − minority interest). Assumes today's earnings approximate steady-state earnings power and ignores any growth premium. See the EPV methodology for assumptions and caveats.

Adjusted (less growth CapEx) matches the normalized variant for this filer — max(0, TTM CapEx $354.1M − TTM D&A $1.16B) = $0 (D&A exceeds CapEx, so the maintenance-CapEx ≈ D&A heuristic doesn't subtract anything). The trail's step 4 walks through the floor.

EPV per share
3-yr avg EBIT margin
-2.22%
× Revenue (forward (divestiture-adjusted))
$15.09B
= Normalized EBIT
-$334.8M
× (1 − tax)
0.7900
= NOPAT
-$264.5M
÷ WACC
12.77%
= Enterprise EPV
+ Excess cash
$2.47B
− Total debt
$5.29B
− Minority interest
$0
= Equity EPV
÷ Diluted shares
855.9M

Normalized NOPAT (3-yr-margin × normalisation revenue, after tax) is non-positive — the no-growth EPV floor is undefined because steady-state earnings power requires positive earnings. The reverse-DCF below models a forward-looking path back to profitability.


EPV full calculation trail Click to expand — every number above derived step by step.

1 · Starting EBIT (TTM)

GAAP operating income from the latest 10-K (FY2026, year ending 2026-01-31). Concept: us-gaap: OperatingIncomeLoss


EBIT (TTM) = $1.32B
                  

2 · Tax rate derivation

Source: 2-year mean of EffectiveTaxRate (third year was negative or untagged). See the tax-rate methodology for the full precedence ladder (3-yr median → 2-yr mean → latest FY → REIT-zero → US-statutory default).

Tax rate = 21.0%
                

3 · Normalized NOPAT

Greenwald's textbook EPV normalises both inputs so a single cyclical or one-time-charge year doesn't whipsaw the floor. Margin anchor: when the filer has at least 8 years of FY EBIT-margin history, the 10-90% trimmed median of every FY observation is preferred — it drops the top and bottom decile so a single boom (COVID supply shock, regulatory one-off) or bust year doesn't anchor the floor. Filers with thinner history fall back to the 3-yr FY mean. Revenue follows a backward-looking ladder: 3-yr FY median → 2-yr FY mean → 1-yr FY → TTM fallback. Analyst forecasts are intentionally excluded — the reverse-DCF below is where forward numbers live, except on filers where the TTM EBIT window carried a material whole-segment disposition gain (the FY revenue base then pre-dates the divestiture and overstates the go-forward business — analyst forward FY consensus is preferred, with TTM as a last fallback). The symmetric case fires for partial-period acquisitions: when an FY in the sampled window carries a filer-disclosed pro-forma revenue tag (BusinessAcquisitionsProFormaRevenue) materially higher than reported, the pro-forma value substitutes into the median/mean so the anchor reflects full-period ownership of the acquired entity. See the EPV methodology for the full recipe.


3-yr FY EBIT margins = mean -2.22%, range [-12.49%, 16.14%]
TTM EBIT margin      = 16.14%

FY revenue history (overridden — TTM EBIT carries a segment-disposition gain):
  FY2026 = $8.19B
  FY2025 = $5.77B
  FY2024 = $5.51B
Revenue (analyst forward FY) = $15.09B   ← overrides FY history because TTM EBIT carried a disposition gain

Normalized EBIT = mean(3-yr margin) × normalisation revenue
                = -2.22% × $15.09B
                = -$334.8M

NOPAT = Normalized EBIT × (1 − tax rate)
      = -$334.8M × 0.7900
      = -$264.5M
                        

4 · Growth CapEx (capex-adjusted variant)

Greenwald's maintenance-CapEx ≈ D&A heuristic. Floored at zero so a filer with CapEx < D&A doesn't get a "negative growth CapEx" bonus added back to NOPAT — that excess D&A is already-paid wear, not earnings. See the EPV methodology .


TTM SBC (non-cash but real economic cost — dilution charge)
= $590.8M
                      
Growth CapEx = max(0, TTM CapEx − TTM D&A)
             = max(0, $354.1M − $1.16B)
             = $0

Adjusted NOPAT = Normalized NOPAT − Growth CapEx
              = -$264.5M − $0
              = -$264.5M
                    

5 · Capitalisation rate (WACC)

Same WACC the reverse-DCF below uses — capital-asset pricing model for cost of equity, synthetic-rating credit spread for cost of debt, market weights from the equity bridge inputs. See the WACC methodology and the full WACC trail under section 4 of the reverse-DCF below.

Cost of equity = Rf + β × ERP
               = 4.3% + 2.04 × 4.5%
               = 13.4%
Cost of debt   = 4.3% (after-tax, synthetic A)
Weights        = E/V 92.9%, D/V 7.1%
WACC           = 12.8%
                    

6 · Enterprise EPV

Enterprise EPV (normalized) = NOPAT ÷ WACC
                            = -$264.5M ÷ 12.8%
                            = —

Enterprise EPV (adjusted)   = (NOPAT − Growth CapEx) ÷ WACC
                            = -$264.5M ÷ 12.8%
                            = —
                

7 · Equity bridge

Same balance-sheet adjustments as the reverse-DCF: add the excess (non-operating) cash an acquirer would pocket at close, subtract the debt that has senior claim on enterprise value, and subtract the noncontrolling interest in consolidated subsidiaries that doesn't accrue to common shareholders. See the balance-sheet aggregates methodology for the exact concept chains.

Enterprise EPV   = —
+ Excess cash    = $2.47B   (after 2%-TTM-revenue operating-cash floor)
− Total debt     = $5.29B
− NCI            = $0
= Equity EPV     = —

Adjusted Equity EPV = — + $2.47B − $5.29B − $0
                    = —
                

8 · Per share & vs market price

Diluted shares         = 855.9M
EPV / share (normalized) = — ÷ 855.9M shares
                       = —
EPV / share (adj.)     = —

Market price           = $78.92
Premium vs price       = (EPV/share − market) ÷ market
                       = —   (normalized), —   (adjusted)
                

Open this EPV in the calculator → Open EPV with 3-yr mean CapEx →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Expectations investing: what does the price imply?

Alternative framing — margin held flat. If margin stayed at TTM -6.2% across the full 10-year horizon (same growth path, same reinvestment policy), fair value would be -$47.25 per share (-159.9% vs the $78.92 market price). The gap of -$124.95 per share is the dollar magnitude of the implied margin compression the price-solved scenario above attributes to the margin axis — the second solver knob the model can't turn while reinvestment is held by the s2c ladder.

Rappaport-style reverse-DCF. We start from the current market price ($78.92 × 855.9M shares = $67.54B market cap, $70.36B enterprise value) and solve for the operating path that would justify it.

To reconcile today's price with a plausible scenario, the model lands on:

  • Year-1 revenue growth: 37.7%
    Scenario holds the analyst consensus of 33.7%.
  • Target EBIT margin (Y10): 18.6%
    Scenario lands above the 3-yr max of 16.1% (starting -6.2%, ending 18.6%).
  • High-growth plateau: 7 years
    7y at 37.8% — few filers sustain that rate that long.

at or below the reference above the reference outside the historical band

Where the PV comes from
Y1–3
-1%
Y4–10
+24%
Terminal
+76%

Share of the total PV the model has assigned to each window. The further out a cash flow sits, the harder it is to estimate — so readers can weigh how much of the scenario rests on the near, plateau, and post-horizon periods.


Facts · FY2026 (2026-01-31)

Share price
$78.92
Diluted shares
855.9M
Total debt
$5.29B
Cash & equivalents
$2.64B
Revenue
$8.19B
EBIT (GAAP)
$1.32B
EBIT margin (GAAP)
16.1%
Less: one-time gains in TTM EBIT
−$1.83B
Underlying TTM EBIT
-$507.5M
Underlying EBIT margin
-6.2%
Operating cash flow
$1.75B
CapEx
$354.1M
Observed YoY growth
42.1%
Analyst current-FY growth
33.7%
Analyst next-FY growth
37.8%
3-year revenue CAGR
11.4%

Assumptions

Initial revenue growth
33.7%
Year-2 growth
37.8%
Starting EBIT margin
-6.2%
Tax rate
6.7% → 21.0%
WACC
12.8%
Starting ROIC
0.0%

Constants

Horizon
10 years
Terminal growth
2.5%
Terminal ROIC
12.8%
Discounting
Mid-year

See the discounting convention, plateau tier rules, and the terminal ROIC fade on the methodology page.


Year-by-year reconciliation

Not a forecast. These are the year-by-year revenue, margin, and cash-flow figures the reverse-DCF solver had to assume for its present value to land on today's enterprise value — the operating path the market price is pricing in, not a view of what the company will deliver.

Year Revenue Growth EBIT Margin NOPAT ROIC Reinvestment FCF Discount PV of FCF
1 $11.28B 37.7% -$419.3M -3.7% -$385.2M 1.3% $0 -$385.2M 0.942 -$362.7M
2 $16.00B 41.8% -$198.6M -1.2% -$179.6M 2.6% $0 -$179.6M 0.835 -$150.0M
3 $22.69B 41.8% $280.0M 1.2% $249.2M 3.8% $249.2M $0 0.740 $0
4 $32.17B 41.8% $1.19B 3.7% $1.05B 5.1% $1.05B $0 0.657 $0
5 $45.63B 41.8% $2.82B 6.2% $2.43B 6.4% $2.43B $0 0.582 $0
6 $64.71B 41.8% $5.61B 8.7% $4.75B 7.7% $3.59B $1.16B 0.516 $597.6M
7 $91.77B 41.8% $10.22B 11.1% $8.51B 8.9% $5.09B $3.42B 0.458 $1.57B
8 $118.12B 28.7% $16.08B 13.6% $13.16B 10.2% $4.96B $8.20B 0.406 $3.33B
9 $136.55B 15.6% $21.97B 16.1% $17.67B 11.5% $3.47B $14.20B 0.360 $5.11B
10 $139.96B 2.5% $25.98B 18.6% $20.53B 12.8% $642.4M $19.89B 0.319 $6.35B
Sum of PV of FCF (years 1-10) $16.44B

Terminal value

NOPATN+1
$21.04B
ReinvestmentN+1
$4.02B
FCFN+1
$17.02B
Terminal value (undiscounted)
$165.68B
PV of terminal value
$52.88B
Gordon-growth: TV = FCFN+1 ÷ (WACC − g) = $17.02B ÷ (12.8% − 2.5%).

Equity bridge

PV of operating FCF $16.44B
+ PV of terminal value $52.88B
= Enterprise value $69.32B
− Total debt $5.29B
+ Excess cash $2.47B
total $2.64B − operating $163.9M (2% × TTM revenue)
= Equity value $66.50B
÷ Diluted shares 855.9M
= DCF PV / share $77.70
Market price $78.92
Reconciliation delta −1.5% (≈ 0 by construction)

Full calculation trail Click to expand — every number on this page derived step by step.

1 · Enterprise-value target (what the DCF must match)

Diluted shares = point-in-time basic × 1.0101× (filer's TSM dilution multiplier from WeightedAverageNumberOfDilutedSharesOutstanding ÷ WeightedAverageNumberOfSharesOutstandingBasic , period ending 2026-01-31 ). See the diluted-shares methodology.

Total debt $5.29B bundles:
  • Long-term debt $4.47B LongTermDebt
  • Short-term borrowings $499.8M ShortTermBorrowings
  • Operating lease liability $319.7M OperatingLeaseLiability
Operating- and finance-lease liabilities and any tagged underfunded pension obligation are folded into total debt as Damodaran-style debt-equivalents on top of the financial-debt concepts; see the total-debt methodology.

Cash is split into the operating floor an operating business needs (2% of revenue, Damodaran heuristic) and the distributable surplus that flows to equity holders. Only excess cash is netted against debt because the DCF values the operating business, and the operating cash stays inside it. Banks, insurers, and REITs are exempt — their cash backs deposits / regulatory reserves / investment portfolios rather than working capital. See the methodology.

Market cap     = price × diluted shares
               = $78.92 × 855.9M
               = $67.54B

Total cash     = $2.64B
Operating cash = 2% × revenue = $163.9M
Excess cash    = max(0, total − operating) = $2.47B

EV target      = market cap + total debt − excess cash
               = $67.54B + $5.29B − $2.47B
               = $70.36B
            

2 · Starting NOPAT (base year 0)

Tax rate source: 2-year mean of EffectiveTaxRate (third year was negative or untagged). See the tax-rate methodology for the precedence ladder.

Tax rate fades from 6.7% at year 0 to 21.0% at year 10 (US federal statutory floor). The current effective rate is the most honest reading of this filer's recent economics, but holding it as the perpetuity rate would compound a one-off NOL benefit / R&D credit / foreign-mix tilt across the whole horizon. WACC's after-tax cost of debt uses the terminal rate so the discount rate is consistent with the long-run cash flows it discounts.

GAAP EBIT          = $1.32B   (16.1% of revenue)
× (1 − tax rate)  = × (1 − 6.7%) = × 0.9328
= NOPAT₀            = -$473.4M
            

3 · Invested capital & starting ROIC

Total debt above includes the operating-lease liability ($319.7M). The corresponding ROU asset sits on the balance sheet and flows through book equity via the accounting identity (E = Assets − Liabilities), so IC reflects the post-ASC-842 operating-capital base without an explicit add-back.

Net deferred-tax position ($304.9M net DTA) stripped from IC. DTAs (NOL / credit carryforwards, post valuation allowance) and DTLs (timing differences from accelerated depreciation) are tax-accounting artifacts, not capital deployed in operations — equity-based IC inadvertently absorbs them via E = Assets − Liabilities, so we back them out so ROIC reflects operating returns on operating capital.

Invested capital = total debt + book equity − excess cash − net deferred tax (DTA)
                 = $5.29B + $14.31B − $2.47B − $304.9M
                 = $16.82B

Raw ROIC₀        = NOPAT₀ / Invested capital
                 = -$473.4M / $16.82B
                 = -2.8%
(no cap applied; raw value is within the 40.0% ceiling)
            

4 · WACC derivation

Cost of equity from CAPM , after-tax cost of debt from a synthetic credit rating built off interest coverage , weighted by market values of equity and debt. Inputs: Rf is FRED DGS10's 90-day mean (latest 2026-05-29); β is the 5-yr weekly regression vs VOO, floored at 1.00 for the cost-of-equity step (the empirical security market line is much flatter than CAPM predicts — Frazzini-Pedersen 2014, "Betting Against Beta" — so unfloored CAPM systematically under-estimates required return for low-β filers); ERP is the latest Damodaran US total ERP (2026-01-01). The synthetic rating is a Damodaran coverage-table heuristic, not an empirical S&P / Moody's letter. It maps EBIT-÷-interest into a letter-grade bucket and reads the spread out of a lookup table; an actual agency rating considers qualitative factors (governance, market position, jurisdiction, off-balance-sheet exposure) the coverage ratio can't capture. For most filers the gap is small; for capital-light, high-coverage names — software, IT services, consumer brands — this method tends to print AAA/AA where actual agency ratings sit at A/BBB+, and the resulting cost of debt is a few tens of bps light. WACC is more sensitive to β and weights than to credit, so the headline barely moves; flagged here so readers don't read the rating as an empirical agency assessment.

Cost of equity        = Rf + β × ERP
                      = 4.3% + 2.04 × 4.5%
                      = 13.4%

Cost of debt (pretax) = Rf + credit spread
                      = 4.3% + 1.1%   (synthetic A, EBIT ÷ interest = 7.1×)
                      = 5.4%
× (1 − tax rate)      = × (1 − 6.7%)
= Cost of debt (a/t)  = 4.3%

Weights               E/V = 92.9%, D/V = 7.1%

WACC (raw)            = E/V × cost_e + D/V × cost_d_after_tax
                      = 92.9% × 13.4% + 7.1% × 4.3%
                      = 12.8%
                

5 · Growth path construction


Source       = analyst consensus: Y1 = 33.7%, Y2 = 37.8%

Detailed derivation:
  Current-FY analyst avg revenue forecast = $10.95B
  Next-FY analyst avg revenue forecast    = $15.09B
  Base revenue (FY2026) = $8.19B

  Y1 = current-FY forecast / FY base revenue − 1
     = $10.95B / $8.19B − 1
     = 33.7%

  Y2 = next-FY forecast / current-FY forecast − 1
     = $15.09B / $10.95B − 1
     = 37.8%
Clamp        = [2.5%, 60%] (no sub-terminal or 60%+ starts)
Plateau rate = 37.8% (Y2 — held from year 2 through end of plateau)
Tier         = 7 years (rule: plateau rate < 15% → 3y, < 25% → 5y, else 7y)
Plateau      = 7 years
Fade         = linear from effective Y2 to terminal 2.5% across the remaining 3 years

Effective Y1 growth after solver bumps = 37.7%
Effective Y2 growth after solver bumps = 41.8%
Growth by year:
  Y1 = 37.7%
  Y2 = 41.8%
  Y3 = 41.8%
  Y4 = 41.8%
  Y5 = 41.8%
  Y6 = 41.8%
  Y7 = 41.8%
  Y8 = 28.7%
  Y9 = 15.6%
  Y10 = 2.5%
                

6 · Margin path construction

Starting margin (Y0) = -6.2%   (source: latest FY EBIT margin (underlying, ex-one-time) — within 4pp of 3-yr mean)
Target margin (Y10)  = 18.6%   (solver output, normal band)
Year-t margin        = starting + (target − starting) × (t / 10)
Margin by year:
  Y1 = -3.7%
  Y2 = -1.2%
  Y3 = 1.2%
  Y4 = 3.7%
  Y5 = 6.2%
  Y6 = 8.7%
  Y7 = 11.1%
  Y8 = 13.6%
  Y9 = 16.1%
  Y10 = 18.6%

Filer-history margin distribution: insufficient history (7 FY available, 8 required); path-stretch flag suppressed.
            

7 · ROIC path construction

The capex heuristic compares latest-period CapEx ($354.1M) against the Normalized CapEx (3-yr mean) of $325.0M — mean of the last three annual CapEx values. When the latest is above 1.4× that mean and CapEx is at least 5% of revenue, we treat the filer as capital-intensive and mid-investment, hold ROIC flat for a 5-year harvest phase, and only then fade to terminal ROIC. The 3-yr mean does not feed the DCF directly — it only gates this flag.

Capex-heuristic inactive (latest CapEx 1.09× the 3-yr mean of $325.0M — below the 1.4× / 5%-of-revenue gates).
Fade from Y1: ROIC_t = ROIC₀ + (ROIC_terminal − ROIC₀) × (t / 10)
ROIC₀ = 0.0%; ROIC_terminal = 12.8%

ROIC by year:
  Y1 = 1.3%
  Y2 = 2.6%
  Y3 = 3.8%
  Y4 = 5.1%
  Y5 = 6.4%
  Y6 = 7.7%
  Y7 = 8.9%
  Y8 = 10.2%
  Y9 = 11.5%
  Y10 = 12.8%
            

7a · Reinvestment formula

The Damodaran growth-firm closure Reinvestment_t = ΔRevenue_t ÷ salesToCapital collapses to noise whenever EITHER the 3-year revenue change OR the 3-year net reinvestment is small relative to the revenue base. The model picks the most-honest formula via a 3-tier ladder: tier-1 standard sales-to-capital fires only when both signals carry magnitude AND the resulting ratio sits inside the typical 0.5–8 band; tier-2 substitutes a TTM (CapEx − D&A) ÷ Revenue ratio applied to each projection year's revenue (not its delta); tier-3 falls through to the ΔNOPAT ÷ ROIC closure when neither signal is usable.

Inputs:
  ΔRev_3y                          = $2.27B
  netReinvest_3y (CapEx − D&A)     = $428.1M
  avgRevenue_3y                    = $7.06B
  TTM CapEx − D&A                  = -$809.6M
  TTM Revenue                      = $8.19B

Tier-1 gates (all three must clear):
  |ΔRev_3y| / avgRev_3y > 1.0%     32.24%         ✓ pass
  netReinv_3y / avgRev_3y > 1.5%   6.07%          ✓ pass
  0.5 ≤ s2c candidate ≤ 8          5.314          ✓ pass

Tier-1 fires.
  salesToCapital = ΔRev_3y ÷ netReinvest_3y = $2.27B ÷ $428.1M = 5.314
  Reinvestment_t = ΔRevenue_t ÷ 5.314
            

8 · Solver iterations

Each row is one configuration in the solver ladder; the "Solved margin" column is the result of bisecting the EBIT margin (up to 80 inner iterations) to match the EV target for that row's plateau / Y1 bump / phase. The solver sweeps Y1 growth bumps 0pp → +20pp across the plateau ladder inside the normal margin bracket, then — if nothing reconciles — repeats the same sweep in a widened margin band ([-10%, 80%]). The first feasible row is the one the page uses. If no combination reconciles, the page shows the row whose PV sits closest to the target EV so both levers are balanced.

# Phase Plateau Y1 bump Solved margin PV(EV) vs target Feasible?
1 normal 7y +0pp 18.6% $55.36B −21.3% no
2 normal 7y +2pp 18.6% $61.97B −11.9% no
3 normal 7y +4pp 18.6% $69.32B −1.5% yes ✓

9 · Terminal value derivation

NOPAT_{N+1}         = NOPAT_{10} × (1 + g_terminal)
                    = $20.53B × (1 + 2.5%)
                    = $21.04B

ΔNOPAT              = NOPAT_{N+1} − NOPAT_{10}
                    = $513.2M
Reinvestment_{N+1}  = ΔNOPAT / ROIC_terminal
                    = $513.2M / 12.8%
                    = $4.02B

FCF_{N+1}           = NOPAT_{N+1} − Reinvestment_{N+1}
                    = $21.04B − $4.02B
                    = $17.02B

Terminal value (TV) = FCF_{N+1} / (WACC − g_terminal)
                    = $17.02B / (12.8% − 2.5%)
                    = $165.68B

PV(TV)              = TV / (1 + WACC)^(10 − 0.5)
                    = $165.68B / 3.133
                    = $52.88B

10 · Reconciliation check (DCF PV vs. the market)

This isn't a fair value — it's the inverse check. The solver built the scenario so that DCF PV reproduces the current enterprise value; if the normal bracket worked the delta below is ~0 by construction. A non-zero delta only appears when the solver fell through to the widened margin band.

Σ PV(FCF_1..10) = $16.44B
+ PV(TV)          = $52.88B
= Enterprise value = $69.32B   (≈ EV target $70.36B by construction)
− Total debt      = $5.29B
+ Excess cash     = $2.47B   (total $2.64B − operating $163.9M)
= Equity value    = $66.50B
÷ Diluted shares  = 855.9M
= DCF PV / share  = $77.70

Market price      = $78.92
Reconciliation Δ  = −1.5%   (≈ 0 by construction — the solver anchored on this price)
                

Open this scenario in the calculator →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Every rule above — growth-source priority, plateau tiers, compound cap, solver ladder, flag colours — is documented on the expectations scenario methodology.

What these ratios mean & how they're built: see the valuation ratios glossary on the Financials methodology page — per-ratio definitions and the exact us-gaap concepts behind each numerator and denominator.

Sources. Denominators come from SEC EDGAR XBRL filings for MRVL (CIK 0001835632); analyst growth forecasts come from analyst consensus. Filing-anchored figures are rendered server-side at the split-adjusted close on the latest reported period-end — so every ratio reconciles to the same filing as every other figure on this page — and the share price, six ratio cards, EPV gap, and reverse-DCF outputs above re-anchor on the most recent daily close in the browser when JavaScript is enabled. The "Full calculation trail" sections stay anchored to the period-end close so the line-by-line arithmetic still reconciles. Per-share denominators are split-adjusted to today's share count.

Related tickers

DDS

Dillard’s, Inc.

MTH

Meritage Homes Corporation

UTMD

UTAH MEDICAL PRODUCTS INC